Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30379% above fair value
$15.71−0.15 (-0.95%)
Close on Nov 13, 2026Market cap $1.68BP/E –Yield –
Personalis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Personalis's enterprise value was $1.48B on Nov 11, 2026, against $801.72M a year earlier. Over the last 5 years it ranged from -$110.96M to $1.57B, with a median of $136.78M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.48B | +167.1% |
| 2025 | Dec 31, 2025 | $555.90M | +110.1% |
| 2024 | Dec 31, 2024 | $264.64M | – |
| 2023 | Dec 29, 2023 | -$17.73M | – |
| 2022 | Dec 30, 2022 | -$101.76M | -130.6% |
| 2021 | Dec 31, 2021 | $332.73M | -72.6% |
| 2020 | Dec 31, 2020 | $1.21B | +472.2% |
| 2019 | Dec 31, 2019 | $212.18M | – |
See a number that looks wrong?